Othmar Zenker
Management
InflaRx
Germany
Biography
Othmar Zenker received his M.D. from the Kiel Medical School in Germany in 1990 and resembles more than 20 years experience in clinical drug development within various internationally operating companies. He served in different lead positions within clinical programs of companies such as Wyeth Pharmaceuticals and CSL Behring. He previousely held a position as Global Head of Immunology at CSL Behring before joining our management team in 2013. Dr. Zenker was heading the clinical R&D programs of InflaRx since 2013 until 2017 as Head of Clinical R&D and has taken on responsibilities for various innovative clinical development programs at InflaRx. He was promoted to Chief Medical Officer in 2017.
Research Interest
Pharmaceutical Science
